Skip to main content

An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents with Attention Deficit Hyperactivity Disorder (ADHD)

Clinical Trial Grant
Duke Scholars

Administered By

Psychiatry & Behavioral Sciences

Awarded By

Sunovion Pharmaceuticals, Inc

Start Date

September 15, 2015

End Date

September 14, 2016
 

Administered By

Psychiatry & Behavioral Sciences

Awarded By

Sunovion Pharmaceuticals, Inc

Start Date

September 15, 2015

End Date

September 14, 2016